Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Immunoprecise Antibodies Ltd

(OTHER OTC: IPATF)
Add to Portfolio
+0.0079 (+1.85%)
as of Feb 19, 2020

Last 0.4357
Change +0.0079 (+1.85%)
Open 0.4498
Prev. Close 0.4278
Today's Range
0.4333
0.4498
52wk Range
0.3286
0.6338
Volume 4,900
Avg Volume 16,110
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
IPATF +1.85% -7.65% -9.42%
DJIA +0.40% +6.03% +13.35%
S&P 500 +0.47% +8.62% +21.81%

Key Statistics

Annual EPS N/A
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K N/A
Weighted Alpha -25.21
Standard Deviation +0.31
Profit Margin N/A
Beta N/A

Growth Rates

YTD -1.04%
1-Year -29.24%
3-Year -61.25%

Opinion

Sell Hold Buy

Recent Headlines

ImmunoPrecise integrates SGI-DNA's benchtop automated

CNW Group via COMTEX - Mon Jan 20, 08:00AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, and SGI-DNA, INC., a company dedicated to d(full story)
IPATF: 0.4357 (+0.0079), IPA.VN: 0.590 (-0.010)

ImmunoPrecise Subsidiary Joins Genmab and Merus in

CNW Group via COMTEX - Thu Jan 09, 08:59AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced that its wholly owned subsi(full story)
IPATF: 0.4357 (+0.0079), IPA.VN: 0.590 (-0.010), GMAB: 24.26 (+0.19), MRUS: 19.44 (+0.29)

ImmunoPrecise Antibodies Will Be in San Francisco

CNW Group via COMTEX - Mon Jan 06, 09:30AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) announced today IPA will be in San Francisco during the J.P. Morgan 38th Annual Healthcare Conference events running from January 13-16, 2020(full story)
JPM: 137.49 (+1.85), IPA.VN: 0.590 (-0.010), IPATF: 0.4357 (+0.0079)

ImmunoPrecise Announces Record Quarterly Revenue and

CNW Group via COMTEX - Tue Dec 17, 09:08AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) announces today that it has released its financial results for the second quarter ended October 31, 2019. The financial statements and relate(full story)
IPA.VN: 0.590 (-0.010), IPATF: 0.4357 (+0.0079)

ImmunoPrecise Announces Annual General Meeting Results

CNW Group via COMTEX - Mon Dec 02, 08:00AM EST
IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) announces that all resolutions were passed by the shareholders at its annual general meeting ("AGM") held in Vancouver, British Columbia, on(full story)
IPATF: 0.4357 (+0.0079), IPA.VN: 0.590 (-0.010)